MRVI reported second-quarter 2026 revenue of $51.4 million, up 8.5% from a year ago and ahead of the Street’s $49.7 million estimate. Maravai LifeSciences Holdings, Inc. also posted a sharp improvement in gross profit, which rose to $20.7 million from the prior-year period.
The company still posted a loss, but the bottom line improved year over year. Operating loss narrowed to $15.1 million, while net loss attributable to common shareholders came in at $12.4 million, or $(0.08) per diluted share.
Cash flow was positive in the quarter, with operating cash flow of $4.0 million. Capital spending remained modest at $0.4 million, while cash and cash equivalents stood at $70.1 million at quarter-end.
- Revenue: $51.4 million, up 8.5% year over year
- Gross profit: $20.7 million, up sharply from a year ago
- Net loss: $12.4 million, or $(0.08) per share
- Operating cash flow: $4.0 million
- Cash and cash equivalents: $70.1 million
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Maravai LifeSciences Holdings, Inc. Insider Trading Activity
Maravai LifeSciences Holdings, Inc. insiders have traded $MRVI stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MRVI stock by insiders over the last 6 months:
- KURT ORESHACK (General Counsel) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $253,999.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Maravai LifeSciences Holdings, Inc. Hedge Fund Activity
We have seen 63 institutional investors add shares of Maravai LifeSciences Holdings, Inc. stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEUTSCHE BANK AG\ added 3,446,672 shares (+401.6%) to their portfolio in Q2 2026, for an estimated $21,507,233
- WELLINGTON MANAGEMENT GROUP LLP removed 2,360,059 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,678,966
- MIRABELLA FINANCIAL SERVICES LLP removed 2,110,545 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,972,842
- 12 WEST CAPITAL MANAGEMENT LP removed 1,661,140 shares (-18.6%) from their portfolio in Q1 2026, for an estimated $4,701,026
- MONACO ASSET MANAGEMENT SAM removed 1,189,994 shares (-34.8%) from their portfolio in Q2 2026, for an estimated $7,425,562
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 1,146,951 shares (+45.4%) to their portfolio in Q2 2026, for an estimated $7,156,974
- CITADEL ADVISORS LLC added 866,865 shares (+140.4%) to their portfolio in Q1 2026, for an estimated $2,453,227
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
